Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Established companies operate an 'execution engine' that values predictability and eliminates failure. This directly conflicts with the 'innovation engine,' which requires uncertainty, experimentation, and learning from failure to discover future value. This fundamental tension is the primary reason corporate innovation initiatives often stall or fail.

Related Insights

An innovation arm's performance isn't its "batting average." If a team pursues truly ambitious, "exotic" opportunities, a high failure rate is an expected and even positive signal. An overly high success rate suggests the team is only taking safe, incremental bets, defeating its purpose.

True innovation isn't about brainstorming endless ideas, but about methodically de-risking a concept in the correct order. The crucial first step is achieving problem clarity. Teams often fail by jumping to solutions before they have sufficiently reduced uncertainty about the core problem.

Corporate creativity follows a bell curve. Early-stage companies and those facing catastrophic failure (the tails) are forced to innovate. Most established companies exist in the middle, where repeating proven playbooks and playing it safe stifles true risk-taking.

While processes are essential for scaling, excessive rigidity stifles the iterative and experimental nature of innovation. Organizations must balance operational efficiency with the flexibility needed for creative breakthroughs, as too much process kills new ideas.

True innovation requires leaders to adopt a venture capital mindset, accepting that roughly nine out of ten initiatives will fail. This high tolerance for failure, mirroring professional investment odds, is a prerequisite for the psychological safety needed for breakthrough results.

In operations, failure is a problem to be eliminated. In innovation, where new ground is being broken, failures are expected and necessary. Instead of being viewed as mistakes, they must be reframed as valuable data points that provide crucial learnings to guide subsequent experiments and decisions.

Disruptive ideas within large companies trigger an organizational "immune system response." Just as biological antibodies attack foreign invaders, the corporate structure, designed for predictability, attacks novel ideas, preventing radical innovation from taking root.

A key reason companies stagnate is the accumulation of "scar tissue": instituting a new, rigid policy for every minor mistake or negative interaction. This behavior creates a risk-averse culture that prevents the "controlled damage" necessary for exploration and rapid learning, ultimately slowing innovation to a halt.

The sensible "crawl, walk, run" approach to innovation is often weaponized as an excuse to never start. Executives, incentivized by legacy models, are scared of eventually having to "run" with a new initiative, so they use the framework to avoid taking the first "crawl" step.

Research across major companies shows that 71% of the time, a solution for a known customer need already exists internally. The primary barrier to innovation isn't a lack of solutions, but the inability for siloed departments to discover and connect existing capabilities with identified customer needs.